Primary information |
---|
sequence ID | Seq_7280 |
Peptide sequence | SLAPYAQDTQEKLNHQLEGLTFQM |
CancerPDF_ID | CancerPDF_ID1394, CancerPDF_ID1444, CancerPDF_ID2632, |
PMID | 21136997,21136997,21136997 |
Protein Name | Apolipoprotein A-IV,Apolipoprotein A-IV,Apolipoprotein A-IV |
UniprotKB Entry Name | APOA4_HUMAN,APOA4_HUMAN,APOA4_HUMAN |
Fluid | Serum,Serum,Plasma |
M/Z | 2777.33304,2761.33813,2761.3381 |
Charge | 1,1,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS |
Quantification Technique | LC-ESI-MS,LC-ESI-MS,LC-ESI-MS |
Labelled/Label Free | Label Free,Label Free,Label Free |
FDR | NA,NA,NA |
CancerPDF_ID | CancerPDF_ID1394, CancerPDF_ID1444, CancerPDF_ID2632, |
p-Value | NA,NA,NA |
Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
Length | 24,24,24 |
Cancer Type | Colorectal cancer,Colorectal cancer,Normal |
Database | SwissProt Database,SwissProt Database,SwissProt Database |
Modification | Oxidation of Met,NA,NA |
Number of Patients | 30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals |
Regulation | NA,NA,NA |
Validation | Leave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | NA |
IEDB | |